InMed Pharmaceuticals Inc (INM) — Working Capital to Net Assets Ratio
InMed Pharmaceuticals Inc (INM) has a Working Capital to Net Assets ratio of 67.1% as of June 2026. Working capital of $721.65 Million (current assets of $2.68 Billion minus current liabilities of $1.96 Billion) is measured against net assets of $1.08 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See InMed Pharmaceuticals Inc (INM) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
InMed Pharmaceuticals Inc Working Capital to Net Assets (2001–2026)
This chart shows how InMed Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 26 annual periods from 2001 to 2026. As of June 2026, the ratio stands at 67.1%, reflecting working capital of $721.65 Million against net assets of $1.08 Billion USD. For the complete balance sheet picture, see balance sheet size of InMed Pharmaceuticals Inc.
Annual Working Capital to Net Assets for InMed Pharmaceuticals Inc (2001–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for InMed Pharmaceuticals Inc from 2001 to 2026, covering 26 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of InMed Pharmaceuticals Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 67.1% | $721.65 Million | $1.08 Billion | $2.68 Billion | $1.96 Billion | ▼ -15.0 pp |
| 2025 | 82.1% | $15.02 Million | $18.30 Million | $17.53 Million | $2.51 Million | ▲ +9.1 pp |
| 2024 | 73.0% | $9.19 Million | $12.59 Million | $11.88 Million | $2.70 Million | ▼ -4.2 pp |
| 2023 | 77.2% | $12.36 Million | $16.02 Million | $15.01 Million | $2.65 Million | ▲ +8.0 pp |
| 2022 | 69.2% | $8.08 Million | $11.69 Million | $12.36 Million | $4.27 Million | ▼ -14.4 pp |
| 2021 | 83.5% | $7.62 Million | $9.12 Million | $10.36 Million | $2.74 Million | ▲ +4.7 pp |
| 2020 | 78.9% | $4.64 Million | $5.88 Million | $6.31 Million | $1.68 Million | ▼ -14.3 pp |
| 2019 | 93.2% | $12.94 Million | $13.88 Million | $14.13 Million | $1.19 Million | ▼ -1.9 pp |
| 2018 | 95.1% | $19.61 Million | $20.62 Million | $20.33 Million | $713.02K | ▲ +12.6 pp |
| 2017 | 82.5% | $5.06 Million | $6.13 Million | $5.34 Million | $284.24K | ▲ +120.5 pp |
| 2016 | -37.9% | $-311.12K | $820.48K | $145.05K | $456.17K | ▼ -48.9 pp |
| 2015 | 10.9% | $139.53K | $1.28 Million | $202.04K | $62.51K | ▲ +3.3 pp |
| 2014 | 7.6% | $115.61K | $1.52 Million | $185.71K | $70.11K | ▼ -92.4 pp |
| 2013 | 100.0% | $-44.11K | $-44.11K | $5.09K | $49.20K | ▲ +0.0 pp |
| 2012 | 100.0% | $2.72K | $2.72K | $47.31K | $44.59K | ▲ +0.0 pp |
| 2011 | 100.0% | $202.29K | $202.29K | $248.50K | $46.20K | ▼ -10.9 pp |
| 2010 | 110.9% | $-1.33 Million | $-1.20 Million | $13.66K | $1.35 Million | ▲ +10.6 pp |
| 2009 | 100.3% | $-1.03 Million | $-1.03 Million | $22.52K | $1.05 Million | ▼ -552.9 pp |
| 2008 | 653.2% | $-907.83K | $-138.98K | $588.33K | $1.50 Million | ▲ +553.0 pp |
| 2007 | 100.2% | $-952.14K | $-950.42K | $361.68K | $1.31 Million | ▼ -31.6 pp |
| 2006 | 131.8% | $-639.85K | $-485.38K | $458.63K | $1.10 Million | ▼ -6.5 pp |
| 2005 | 138.3% | $-927.80K | $-670.63K | $626.16K | $1.55 Million | ▼ -75.6 pp |
| 2004 | 213.9% | $-503.93K | $-235.55K | $251.39K | $755.33K | ▲ +236.5 pp |
| 2003 | -22.6% | $-54.57K | $241.85K | $414.47K | $469.04K | ▼ -95.9 pp |
| 2002 | 73.3% | $944.80K | $1.29 Million | $1.02 Million | $74.45K | ▲ +28.4 pp |
| 2001 | 44.9% | $1.88 Million | $4.18 Million | $2.37 Million | $493.02K | — |